Hepatitis C Support Group
Hepatitis C is a blood-borne viral disease which can cause liver inflammation, fibrosis, cirrhosis and liver cancer. The hepatitis C virus (HCV) is spread by blood-to-blood contact with an infected person's blood. Many people with HCV infection have no symptoms and are unaware of the need to seek treatment. Hepatitis C infects an estimated 150-200 million people worldwide.
Oh please please please??!!!!!!!
(Reuters) - Gilead Sciences Inc is on track to file for regulatory approval of sofosbuvir, its treatment for chronic hepatitis C virus (HCV) infection, starting in mid-2013, the biotech company said on Monday.
http://www.reuters.com/article/2013/01/07/us-gilead-hepatitis-idUSBRE9060FV20130107
(Reuters) - Gilead Sciences Inc is on track to file for regulatory approval of sofosbuvir, its treatment for chronic hepatitis C virus (HCV) infection, starting in mid-2013, the biotech company said on Monday.
http://www.reuters.com/article/2013/01/07/us-gilead-hepatitis-idUSBRE9060FV20130107
once Daily fixed dose of combo meds tablet!.. Oh boy, :)
http://www.fortmilltimes.com/2013/01/07/2419763/gilead-provides-update-on-hepatitis.html
LOVING that site you sent Kramer (for the avies).
Bump for RASS
Gilead has one coming to Gainesville Fl & I can handle that drive.
One in Tampa excluded me because of the double blind trial I was in, 2009.
I'm curious about a few things. Nowhere does it say that they're applying for 5885 approval yet.That's the drug they started pairing it with that is getting amazing results. Prior to that they had success pairing it with daclatasvir (BMS) but I don't think BMS are applying for approval soon. So, if what I surmise is correct, when it's approved it will be with IFN/Riba for 12 weeks. Still pretty damn good but won't help those who can't take IFN.
Just my thoughts, any feedback would be welcome. But really, this is fantastic news however things play out initially.